Kevzara (sarilumab) Approved by FDA as First and Only Biologic Indicated for Patients with…
Regeneron Pharmaceuticals, Inc. and Sanofi announced that the U.S. Food and Drug Administration (FDA) has approved Kevzara (sarilumab) for the treatment of polymyalgia rheumatica (PMR),…
Read More...
Read More...
